Highly Active Antiretroviral Therapy in an Extremely Low Birth Weight Newborn With in Utero Transmission of HIV
- PMID: 36795550
- DOI: 10.1097/INF.0000000000003857
Highly Active Antiretroviral Therapy in an Extremely Low Birth Weight Newborn With in Utero Transmission of HIV
Abstract
The management of perinatal HIV infection in preterm infants is hampered by the lack of evidence informing optimal antiretroviral treatment for these vulnerable newborns. We present a case of an extremely preterm infant with HIV infection treated immediately with a 3-drug antiretroviral regimen and achieving stable suppression of HIV plasma viral load.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Tooke L, Horn AR, Harrison MC. HIV transmission to extremely low birth weight infants. Pediatr Infect Dis J. 2013;32:36–38.
-
- Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the use of antiretroviral agents in pediatric hiv infection. Avaible at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Pe... .
-
- Luzuriaga K, McManus M, Catalina M, et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1- specific immune responses. J Virol. 2000;74:6984–6991.
-
- Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Eng J Med. 2013;369:1828–1835.
-
- Butler K, Gavin P, Coughlan S, et al. Rapid viral rebound after 4 years of suppressive therapy in a seronegative HIV-1 infected treated from birth. Pediatr Infect Dis J. 2015;34:e48–e51.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical